Gallbladder cancer-associated thrombotic microangiopathy

Future Oncology

Volumn 9, Issue 11, 2013, Pages 1711-1715

  Gonsalves, Wilson I ^a   Gupta, Vinay ^a   Smeltzer, Jacob P ^a   Singh, Preet P ^a   McWilliams, Robert R ^a   Gangat, Naseema ^a  

^a MAYO CLINIC   (United States)

Author keywords

gallbladder cancer; plasma exchange; thrombocytopenic purpura; thrombotic microangiopathy

Indexed keywords

CISPLATIN; GEMCITABINE;

ADENOCARCINOMA; ADULT; ARTICLE; BONE MARROW METASTASIS; CANCER ASSOCIATED THROMBOTIC MICROANGIOPATHY; CANCER PALLIATIVE THERAPY; CASE REPORT; CHOLECYSTECTOMY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; TUMOR VOLUME;

ABORTION, THERAPEUTIC; ADENOCARCINOMA; ADULT; CHEMOTHERAPY, ADJUVANT; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; THROMBOTIC MICROANGIOPATHIES;

EID: 84887293538     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.144     Document Type: Article

References (16)

1. Lesesne JB, Rothschild N, Erickson B et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national regis t r y. J. Clin. Oncol. 7(6), 781-789 (1989).
2. Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, Lammle B. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe defciency of the von Willebrand factor-cleaving protease. Br. J. Haematol. 113(1), 100-102 (2001).
3. Elliott MA, Letendre L, Gastineau DA, Winters JL, Pruthi RK, Heit JA. Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur. J. Haematol. 85(1), 43-50 (2010).
4. Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofbrosis in cancer. Oncologist 8(4), 375-380 (2003).
5. Rock GA. Management of thrombotic thrombocytopenic purpura. Br. J. Haematol. 109(3), 496-507 (2000).
6. Halevy D, Radhakrishnan J, Markowitz G, Appel G. Thrombotic microangiopathies. Crit. Care Clin. 18(2), 309-320 (2002).
7. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. Oncologist 12(1), 11-19 (2007).
8. Furlan M, Robles R, Galbusera M et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N. Engl. J. Med. 339 (22), 1578-1584 (1998).
9. Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 103(11), 4043-4049 (2004).
10. Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore) 58(5), 377-384 (1979).
11. Sakashita N, Yokose C, Fujii K, Matsumoto M, Ohnishi K, Takeya M. Pulmonary tumor thrombotic microangiopathy resulting from metastatic signet ring cell carcinoma of the stomach. Pathol. Int. 57(6), 383-387 (2007).
12. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol. To d a y 18(10), 483-486 (1997).
13. Oberic L, Buffet M, Schwarzinger M et al. Cancer awareness in atypical thrombotic microangiopathies. Oncologist 14(8), 769-779 (2009).
14. Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Tr a n s f u s i o n 46 (1), 154-156 (2006).
15. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin. Thromb. Hemost. 25(2), 217-221 (1999).
16. Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N. Engl. J. Med. 325(6), 393-397 (1991).